Claims of benefits of aromatherapy for cancer patients include reduced anxiety levels and relief of emotional stress, pain, muscular tension and fatigue. The objective of this paper is to provide an updated descriptive, systematic review of evidence from pre-clinical and clinical trials assessing the benefits and safety of aromatherapy for cancer patients. Literature databases such as Medline (via Ovid), the Cochrane database of systematic reviews, Cochrane Central were searched from their inception until October 2010. Only studies on cancer cells or cancer patients were included. There is no long lasting effect of aromatherapy massage, while short term improvements were reported for general well being, anxiety and depression up to 8 weeks after treatment. The reviewed studies indicate short-term effects of aromatherapy on depression, anxiety and overall wellbeing. Specifically, some clinical trials found an increase in patient-identified symptom relief, psychological wellbeing and improved sleep. Furthermore, some found a short-term improvement (up to 2 weeks after treatment) in anxiety and depression scores and better pain control. Although essential oils have generally shown minimal adverse effects, potential risks include ingesting large amounts (intentional misuse); local skin irritation, especially with prolonged skin contact; allergic contact dermatitis; and phototoxicity from reaction to sunlight (some oils). Repeated topical administration of lavender and tea tree oil was associated with reversible prepubertal gynecomastia.
Introduction
Aromatherapy encompasses the use of essential oils derived from different types of plant sources for a variety of application methods. Generally, the whole fresh plant (not crushed or powdered) is used for the essential oil distillation process. The specific ingredients of an essential oil are derived from plant materials or parts that are claimed to possess therapeutic properties. Essential oils are "the steam distillate of aromatic plants" (Tisserand and Balacs, 1995) . They have been described as "the volatile, organic constituents of fragrant plant matter and contribute to both flavor and fragrance and are extracted either by distillation or by cold pressing (expression)" (Tisserand and Balacs, 1995) . The history of distillation of essential oils started with the medieval physician Avicenna (Abu Ali al-Hussein Ibn Abdallah Ibn Sina; 980 -1037) from Persia who invented the process of distillation and was probably the first to distil oil of the rose plant (Tisserand, 1988 ). Today, approximately 40 different oils derived from plants are used in aromatherapy. Lavender, rosemary, eucalyptus, chamomile, marjoram, jasmine, peppermint, lemon, ylang ylang, and geranium are some of the most popular.
The term 'aromatherapy' was coined by French chemist and perfumiér René Maurice Gattefossé in the 1920s and is a subcategory of 'herbal medicine' (Gattefosse, 1993 ). Gattefossé's book was published in 1937. He suggested that aromatherapy could be used to treat diseases in virtually every organ system, citing mostly anecdotal and case-based evidence. In the 1960s, aromatherapy was revived by the French homeopath Dr. Maury, and in the 1980s it increased in popularity in the United States. It is fairly well-established in Australia, Canada, France, Germany, New Zealand, Switzerland and the UK.
There are various forms of application. Most commonly, oils are applied topically in diluted forms, often together with a carrier oil as part of massage therapy to manipulate the soft tissue of the body, or by using an incense burner for inhalation of the aroma. Essential oils may be inhaled by adding a few drops to steaming water, thereafter an atomizer or humidifier spreads the aroma throughout the room. Certain aromatherapy oils are also ingested through teas, whereas others can be added to bathwater or pillows, or used to make ointments, creams and compresses. Some aromatherapists argue that the use of certain herbs in food can also be considered part of aromatherapy, although this should be considered as a specific alimentation rather than a precise use as essential oils.
Literature databases such as Medline (via Ovid), the Cochrane database of systematic reviews, Cochrane Central were searched from their inception until October 2010. The main search terms were 'aromatherapy' AND 'cancer'. For specific literature search procedures see Table 1 (OVID) and Table 2 (Cochrane Central and Cochrane database of systematic reviews). As this review was supposed to be comprehensive, we decided to also include results from pre-clinical studies on cancer cells. Thus, studies on cancer cells or cancer patients were included. The quality of publications was assessed by looking at the internal validity (study design and conduct), external validity (applicability and generalizability of results) and summarizing the direction of evidence (positive, uncertain, negative).
Results
One systematic review, 18 clinical trials and a selected number of pre-clinical trials are summarized here. Further data are presented in Tables 3 and 4 . Safety aspects are also discussed.
Systematic reviews
Yim et al (2009) carried out a systematic review specifically including trials for aromatherapy for depression (Yim et al., 2009) . They included six studies applying aromatherapy massage in patients with depression. Three of the included studies evaluated the benefit of Swedish massage (two with lavender oil) for depressive symptoms of patients with cancer (mainly women with breast cancer). Results showed significant short term-improvement in anxiety and/or depression compared with usual care. No effect sizes were described. According to the authors this might be explained by an induction of a relaxation response in the autonomic nervous system. However, there was no adequate control intervention (i.e., massage without essential oils), and thus the relevance of this finding remains elusive.
Clinical trials
All clinical studies which applied essential oils with or without massage to cancer patients were included. Table 3 ). The evidence of these trials points to a short-term benefit of aromatherapy / essential oils which could possibly last up to 2 weeks with reduction in anxiety and depression scores, improved sleep and an overall increase in wellbeing. Some of these trials also found an increase in patient-identified symptom relief and psychological wellbeing. However, other trials did not report any significant difference between groups. Since the comparator interventions used in the included trials vary greatly, it is not possible to assess the system and component efficacy of specific essential oils. The quality of publications ranged from mediocre to low. Double-blinding is practically impossible in the field of aromatherapy.
In conclusion, existing evidence provides weak evidence that aromatherapy might have some short-term effects on anxiety and depression, and possibly on pain relief. However, it is unclear whether this is a matter of positive expectation or a pharmacologically mediated effect.
Pre-clinical trials
There is considerable published research available on the in vivo and in vitro anti-inflammatory, anti-oxidant, antibacterial, antifungal, and antiviral activity of a number of essential oils. Furthermore, the cytotoxic, free radical scavenging, carcinogenetic, apoptosis inducing and anti-neoplastic effects of a number of essential oils has been investigated in pre-clinical trials (Gould, 1997) . For a summary of the selected pre-clinical studies see Table 4 , 1992) . However, the concentrations applied in the respective studies might not be comparable to those in conventional aromatherapy, either volatile or directly resorbed.
Safety aspects
It is generally accepted by aromatherapists that a safe and effective dilution for most aromatherapy/essential oils in massage therapy is a maximum of 2.5 % for adults, which translates to 2 drops of essential oil per 100 drops of carrier oil (2% dilution: 10-12 drops of essential oil per ounce of carrier oil). For full-body baths, the dosage of essential oil is usually 5-10 drops per bath. As long as practitioners know how to dilute them, non-toxic essential oils used on the skin are unlikely to harm the patient. The testing of essential oils for safety has shown minimal adverse effects. A number of oils have therefore been approved for use as food additives and are classified as GRAS (generally recognized as safe) by the U.S. Food and Drug Administration (US Food and Drug Administration). There is, however, a risk involved with ingestion of large amounts of essential oils. For instance, severe, extensive, life threatening phototoxic reactions, such as the case of a woman who died of a massive phototoxic skin reaction, have been described after ingestion of food and medication containing psoralen and subsequent exposure to artificial UV radiation (Kaddu et al., 1998).
Some essential oils (e.g. camphor oil) can cause local irritation. The main safety issue with essential oils seems to be that cases of contact dermatitis have been reported, mostly in aromatherapists who have had prolonged skin contact with oils in the context of aromatherapy massage. In a mailed 2004 survey including members of a national massage therapy organization in the greater Philadelphia region found that the 12-month prevalence of hand dermatitis in subjects was 15% by self-reported criteria and 23% by a symptom-based method (Crawford et al., 2004) . This problem had also been reported much earlier in the UK (Bilsland and Strong, 1990 ). Repeated exposure to lavender and tea tree oils by topical administration was shown in one study to be associated with reversible prepubertal gynecomastia (Henley et al., 2007) . The respective effect appears to have been caused by the purported weak estrogenic and antiandrogenic activities of lavender and tea tree oils. Therefore, these two essential oils could cause problems in patients with estrogen-dependant tumors. A review on the safety assessment of St John's Wort (Hypericum perforatum) oil concluded that the available data are insufficient to support the safety of ingredients from this plant in cosmetic formulations (Anonymous, 2001 ).
Discussion
Findings on the interventional use of aromatherapy in cancer patients suggests a short-term benefit to reduce anxiety and depression, improve sleep and increase overall wellbeing; this effect has been suggested to last up to 2 weeks. Some of the trials Records identified through database searching (n =84)
Additional records identified through other sources (n = 12)
Records after duplicates removed (n = 96)
Records screened (n = 96)
Records excluded (n = 71)
Full-text articles assessed for eligibility (n = 25)
Full-text articles excluded, with reasons (n = 7)
Studies included in overview (n = 18) Group (1) showed significant improvement in clinical anxiety and/or depression compared with (2) at 6 weeks (P=0.1), but not at 10 weeks post randomization.
(1) also described greater improvement in self-reported anxiety at both 6 and 10 weeks post-randomization (P=0.04 and P=0.04)
Aromatherapy massage did not appear to confer benefit on cancer patients' anxiety and/or depression in the longterm, but may be associated with clinically important benefit up to 2 weeks after the intervention RCT -randomized clinical trial, CCT -clinical controlled trial, UCT -uncontrolled clinical trial also found an increase in patient-identified symptom relief and psychological wellbeing. However, other trials did not report any significant difference between groups. Since the comparator interventions used in the included trials vary greatly, it was not possible to make an easy assessment regarding the system and component efficacy of specific essential oils. Although there were some RCT, the quality of publications ranges from mediocre to low. In particular, double-blinding as a quality marker of clinical trials is nearly impossible in trials in the field of aromatherapy, and thus study quality tends to be lower compared to conventional pharmacological trials. Moreover, adequate control interventions are needed. For example, massage therapy generally has a positive effect on the recipient and most positive effects discussed above stem from trials that in adjunction apply essential oils. Thus, it is difficult to be certain as to where exactly the reason for a positive effect lies. However, wellbeing and offering these effects in a package are of limited harm and thus some cancer clinics or other voluntary organizations now offer aromatherapy or aromatherapy massage free of charge or at a lower cost. The cost of essential oils varies depending on the quality, i.e. what part of the plant the oil is extracted from and which method that was used to extract it. Oils may be purchased from a licensed aromatherapist. For instance, essential oil from rose petals retails at €100 per ounce (appr. 28 grams) -based on the 110 pounds (50 kg) of rose petals needed for a single ounce of essential oil. Other plants retail at much lower prices as they yield more essential oil (for instance lavender, lemon, and eucalyptus). Lavender can be bought at €22 per ounce. Treatments of aromatherapy usually are priced from €40 to €75 for a 90 minute session.
The number of theories that try to explain the mechanism of aromatherapy can be categorized into psychological aspects and neuro-chemical effects. Proposed mechanisms claim effects on the limbic and olfactory system, which in turn is suggested to have an effect on mood (Diego et al., 1998) . However, only very limited research confirms effectiveness or mechanism of action and in-depth studies have yet to shed sufficient light on these possible mechanisms and the connection between the olfactory and limbic system. Proponents of essential oils / aromatherapy also believe that the effects these oils have on the body are greater than the sum of the individual components of the scents (Perry and Perry, 2006) . Furthermore, there are various discussions amongst aromatherapists as to whether natural oils are superior to synthetic ones. Currently, there are no references to scientific studies of the issue.
Limitations
The limitations of this descriptive, systematic review include the fact that despite modern search engines and wellorganized literature databases sometimes it is impossible to identify all the 'grey literature' regarding one topic. Thus, it is possible that the one or other study or case series is not included in this review. For instance, the medical search engine EMBASE was not searched. Furthermore, outcome measures and study designs of included studies varied to an extent that meta-analyzing the data was omitted due to heterogeneity.
As providers of essential oils are numerous and widespread in countries where aromatherapy is practiced, mainly on the European, North American, Australasian and Asian continents, comparability in trials with the same substance still may result in different outcomes. Moreover, training of aromatherapists and courses offered by some colleges and schools do not have a concerted curriculum which also includes a potential source of bias.
Conclusion
In summary, the use of diluted essential oils has minimal risks. Prolonged topical application may nevertheless cause allergic contact dermatitis. Repeated exposure to lavender and tea tree oils by topical administration was shown in one study to be associated with reversible prepubertal gynecomastia. Thus, patients with estrogen-dependant tumors should exercise caution. Aromatherapy/essential oils may be used safely by cancer patients for a short-term benefit in regard to reducing anxiety and depression symptoms and to increase sleep patterns and wellbeing.
